Assessment of the Different Etiological and Susceptibility Markers in Patients With Pancreatitis: Investigating IG4, Cytomegalovirus, Coxsackie- Virus, Genetic Polymorphism of Vitamin D Receptor Gene
NCT03830073 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2019-02-05
Summary
Acute pancreatitis (AP) is a multifactorial disease. AP represents a significant number of hospital admissions. Most of the patients are admitted in an acute setting. Early identification of its etiology is an essential step toward the rational approach, both for its implications in the immediate therapy and the prevention of recurrence. Although often obvious, the etiological workup of acute pancreatitis can be challenging.
Conditions
Interventions
- GENETIC
-
Measurement of VDR genetic polymorphism
VDR genetic polymorphism will be measured by RFLP and correlated with viral, autoimmune markers.
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Min Age
- 20 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-03-01
- Primary Completion
- 2019-06-01
- Completion
- 2019-06-20
More Related Trials
-
Association of Vitamin D Binding Protein Polymorphisms With Response to HCV Therapy
NCT02788682 ·Status: COMPLETED
-
Cytokines and the Risk of Infection in Liver Cirrhosis
NCT00857181 ·Status: TERMINATED
-
CMV Reactivation in Acute Necrotizing Pancreatitis
NCT05898048 ·Status: COMPLETED
-
Prediction of Acute Pancreatitis Outcome
NCT06653205 ·Status: NOT_YET_RECRUITING
-
Evaluating the Role of Immune Responses in the Emergence of Protease Inhibitor Mutations
NCT01517529 ·Status: COMPLETED
-
Dose Effect Relationship of MTX and IBD
NCT03531593 ·Status: COMPLETED
-
Neutrophil/Lymphocyte Ratio in Acute Pancreatitis
NCT05859633 ·Status: UNKNOWN
-
Prospective Clinical Study of the Role of the Immune Response, in Relation to Diet, in Patients Affected by Either Chronic Hepatitis C Virus (HCV) Infection or Non Alcoholic Fatty Liver Disease (NAFLD)
NCT02038387 ·Status: UNKNOWN ·Phase: NA
-
Predictors of Subclinical Atherosclerotic Cardiovascular Diseases (ASCVD) in Patients With Inflammatory Bowel Disease
NCT03868332 ·Status: UNKNOWN
-
Prevalence of H.Pylori in CKD Patients
NCT05882968 ·Status: UNKNOWN
-
Examining Macrophage Influx and Vascularization in Chronic Pancreatitis
NCT00491023 ·Status: COMPLETED
-
Frequency and Risk Factors for Autoimmune Disorders and Rheumatic Manifestations in Egyptian Patients With IBD
NCT05771363 ·Status: UNKNOWN
-
Albumin Modifications as Early Biomarkers of Chronic Liver Diseases
NCT06318949 ·Status: RECRUITING ·Phase: NA
-
Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis
NCT02257866 ·Status: RECRUITING
-
Genetic Analysis for Predicting of Relapse During Steroid Treatment for Autoimmune Pancreatitis (AIP)
NCT00444444 ·Status: COMPLETED
-
Plasma Citrulline Concentration in Tropical Enteropathy
NCT00816842 ·Status: COMPLETED
-
Immun Status at Pancreatitis Patients
NCT03937323 ·Status: COMPLETED
-
C-reactive Protein & Albumin Ratio IN AKI
NCT07335757 ·Status: NOT_YET_RECRUITING
-
Proteogenomic Monitoring and Assessment of Liver Transplant Recipients
NCT01644903 ·Status: RECRUITING
-
Data Collection and Identification of Infection-responsible Bacterial Resistances in Cirrhotic Patients
NCT03965260 ·Status: COMPLETED
-
The Characteristics of Oral Microbiota in Chronic Pancreatitis and Autoimmune Pancreatitis
NCT07015580 ·Status: RECRUITING
-
Surveillance for Early Liver Injuries Caused by Zhuanggu Guanjie Pill
NCT03060252 ·Status: UNKNOWN
-
Hs-CRP as Clinical Marker of Inflammatory Atherogenic Dyslipidemia
NCT00169871 ·Status: COMPLETED
-
Role of Coagulation, Inflammation and Vessels in Chronic Liver Disease
NCT05865691 ·Status: RECRUITING
-
Pathology of Hepatitis c Nephropathy
NCT03476031 ·Status: UNKNOWN